Appointment booking for Dr. Brian Gebhart, DO is currently not available.Dr. Brian Gebhart, DO has not yet fully activated their profile on DiabetesIQ.
Dr. Brian Gebhart, DO (he/him) is a Surgeon in Normal, IL with over 18 years of experience. What is your opinion of Dr. Brian Gebhart, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Brian Gebhart, DO has received over $7,590 which includes payments from the following companies:
$4,546.25 from Intuitive Surgical, Inc.
$1,378.63 from Davol Inc.
$330.18 from LifeCell Corporation
$177.97 from Mallinckrodt LLC
$151.30 from Ethicon US, LLC
$126.56 from KCI USA, Inc
$85.76 from Pacira Pharmaceuticals Incorporated
$84.91 from Shire North American Group Inc
$84.21 from CSL Behring
$79.62 from Baxter Healthcare
$72.86 from Covidien Sales LLC
$67.76 from Salix Pharmaceuticals, Ltd
$65.52 from Valeant Pharmaceuticals North America LLC
$44.80 from KARLSTORZ Endoscopy-America
$43.37 from Covidien LP
$36.27 from TEI Biosciences Inc
$31.16 from DePuy Synthes Sales Inc.
$28.65 from Olympus America Inc.
$26.54 from Novadaq Technologies Inc.
$25.69 from Hospira Worldwide, Inc.
Payments received by Dr. Brian Gebhart, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!